Ranibizumab for serous macular detachment in branch retinal vein occlusions

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 1, 2013, Pages 9-14

  Gallego Pinazo, Roberto ^a   Dolz Marco, Rosa ^a   Pardo López, Diamar ^a   Martínez Castillo, Sebastián ^a   Lleó Pérez, Antonio ^b   Arévalo, J Fernando ^c,d   Díaz Llopis, Manuel ^a,e  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Hospital of Requena   (Spain)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Branch retinal vein occlusion; Macular edema; Optical coherence tomography; Ranibizumab; Serous macular neuroretinal detachment

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MACULAR THICKNESS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL DETACHMENT; RETINAL VEIN OCCLUSION; RETREATMENT; SERUM; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84872345924     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2023-7     Document Type: Article

References (16)

1. Hayreh S (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24:493-519
2. Margolis R, Singh RP, Kaiser PK (2006) Branch retinal vein occlusion: clinical findings, natural history, and management. Compr Ophthamol Update 27:265-76
3. Shilling JS, Jones CA (1984) Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 68:196-8
4. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, Investigators BRAVO (2010) Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1102-12
5. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, Investigators CRUISE (2010) Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1124-33
6. Campochiaro PA, Hafiz G, Channa R, Shah SM, Nguyen QD, Ying H, Do DV, Zimmer-Galler I, Solomon SD, Sung JU, Syed B (2010) Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology 117:2387-2394
7. Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G (2010) Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Acta Ophthalmol. PMID:20602625
8. Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I (2010) Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Retina 30:893-902
9. Hoeh AE, Ruppenstein M, Ach T, Dithmar S (2010) OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248:1567-72
10. Shin HJ, Chung H, Kim HC (2011) Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion. Acta Ophthalmol 89:e35-40
11. Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Yoshimura N (2007) Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol 91:1644-9
12. Shroff D, Mehta DK, Arora R, Narula R, Chauhan D (2008) Natural history of macular status in recent-onset branch retinal vein occlusion: an optical coherence tomography study. Int Ophthalmol 28:261-8
13. Spaide RF, Lee JK, Klancnik JK Jr, Gross NE (2003) Optical coherence tomography of branch retinal vein occlusion. Retina 23:343-7
14. Ohashi H, Oh H, Nishiwaki H, Nonaka A, Takagi H (2004) Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion. Ophthalmology 111:2050-6
15. Cinal A, Ziemssen F, Bartz-Schmidt KU, Gelisken F (2011) Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 249:513-20
16. Burak T, Fatih CG, Tamer D (2010) The causes of serous macular detachment excluding central serous chorioretinopathy. Clin Optom 2:51-54